BioLargo Inc (BLGO)
OTHER OTC:BLGO
US Market
Holding BLGO?
Track your performance easily

BioLargo (BLGO) Financial Statements

57 Followers

BioLargo Financial Overview

BioLargo's market cap is currently ―. The company's EPS TTM is $-0.009; its P/E ratio is -25.31; BioLargo is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 5.01M$ 4.76M$ 4.37M$ 2.67M$ 1.45M
Gross Profit$ 2.14M$ 2.25M$ 1.96M$ 1.50M$ 819.00K
EBIT$ -890.00K$ -398.00K$ -1.00M$ -1.50M$ -1.61M
EBITDA$ -830.00K$ -338.00K$ -913.00K$ -1.42M$ -1.53M
Net Income Common Stockholders$ -441.00K$ -410.00K$ -729.00K$ -1.20M$ -1.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.76M$ 4.34M$ 3.54M$ 3.04M$ 3.58M
Total Assets$ 10.05M$ 9.82M$ 8.21M$ 6.54M$ 6.68M
Total Debt$ 1.25M$ 2.36M$ 1.40M$ 1.15M$ 1.18M
Net Debt$ -3.51M$ -1.98M$ -2.14M$ -1.89M$ -2.39M
Total Liabilities$ 4.16M$ 4.65M$ 4.00M$ 2.73M$ 2.56M
Stockholders Equity$ 6.00M$ 8.12M$ 6.84M$ 7.07M$ 7.37M
Cash Flow-
Free Cash Flow$ -509.00K$ -382.00K$ -148.00K$ -1.04M$ -1.56M
Operating Cash Flow$ -151.00K$ 481.00K$ -2.00K$ -836.00K$ -1.48M
Investing Cash Flow$ -358.00K$ -863.00K$ -146.00K$ -205.00K$ -79.00K
Financing Cash Flow$ 999.00K$ 1.08M$ 761.00K$ 507.00K$ 1.88M
Currency in USD

BioLargo Earnings and Revenue History

BioLargo Debt to Assets

BioLargo Cash Flow

BioLargo Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis